![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Bhuiyan Md. Shenuarin Fukunaga Kohji
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.15, Iss.2, 2011-02, pp. : 145-155
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
Current Neuropharmacology, Vol. 6, Iss. 4, 2008-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Are cannabinoids endogenous ligands for the VR1 capsaicin receptor?
Trends in Pharmacological Sciences, Vol. 21, Iss. 2, 2000-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sigma-2 Receptor Ligands: Neurobiological Effects
Current Medicinal Chemistry, Vol. 22, Iss. 8, 2015-03 ,pp. :